Address
Email address
Phone number
https://miecys.eeTerviteek.ee - Parema enesetunde nimel!Hematogeen, Humer ja teised tuntud tooted otse maaletoojalt. Kiire tarne pakiautomaati või kulleriga koju. Leia parimad pakkumised e-poest!
Name
osaühing MIECYS-PHARM
Registry code
10134440
VAT number
EE100030475
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.10.1996 (29)
Financial year
01.01-31.12
Capital
2 550.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
2 813 052 €
130 122 €
6%
3 488 €
(estimate is approximate)
824 285 €
9
-
No tax arrears
16%
11%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Darius Valba
| - | Board member | - | |
| Kirke Pentikäinen
| - | Board member | - | |
| Anu Jürgenson
| 10% - 255.00 EUR | - | - | |
| Roma Mačienė
| 80% - 2 040.00 EUR | - | - |
| 2019 31.05.2020 | 2020 09.06.2021 | 2021 09.05.2022 | 2022 26.06.2023 | 2023 27.06.2024 | 2024 17.06.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 2 775 460 € | 2 268 551 € | 1 563 317 € | 1 742 641 € | 2 054 671 € | 2 048 523 € |
| Net profit (loss) for the period | 53 062 € | 4 443 € | -34 953 € | 47 148 € | 130 122 € | 67 900 € |
| Profit Margin | 2% | 0% | -2% | 3% | 6% | 3% |
| Current Assets | 1 518 203 € | 1 043 191 € | 871 558 € | 970 106 € | 1 224 771 € | 1 048 628 € |
| Fixed Assets | - | - | 1 535 € | 1 132 € | 0 € | - |
| Total Assets | 1 518 203 € | 1 043 191 € | 873 093 € | 971 238 € | 1 224 771 € | 1 048 628 € |
| Current Liabilities | 711 777 € | 233 672 € | 226 078 € | 277 075 € | 400 486 € | 156 443 € |
| Non Current Liabilities | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - |
| Share Capital | - | - | - | - | - | - |
| Equity | 806 426 € | 809 519 € | 647 015 € | 694 163 € | 824 285 € | 892 185 € |
| Employees | 4 | 4 | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 1 007 590 € | 104 514 € | 19 985 € | 3 |
| 2025 Q3 | 678 769 € | 77 893 € | 18 388 € | 3 |
| 2025 Q2 | 675 904 € | 87 575 € | 18 753 € | 3 |
| 2025 Q1 | 894 211 € | 95 312 € | 21 002 € | 3 |
| 2024 Q4 | 900 115 € | 103 795 € | 17 629 € | 3 |
| 2024 Q3 | 566 776 € | 66 397 € | 17 832 € | 3 |
| 2024 Q2 | 786 071 € | 76 124 € | 20 080 € | 3 |
| 2024 Q1 | 981 098 € | 102 649 € | 21 385 € | 3 |
| 2023 Q4 | 1 253 845 € | 111 154 € | 15 738 € | 3 |
| 2023 Q3 | 573 564 € | 62 683 € | 13 484 € | 3 |
| 2023 Q2 | 663 524 € | 74 057 € | 16 237 € | 2 |
| 2023 Q1 | 828 350 € | 123 868 € | 43 387 € | 3 |
| 2022 Q4 | 602 689 € | 81 547 € | 19 468 € | 3 |
| 2022 Q3 | 732 506 € | 74 781 € | 19 244 € | 3 |
| 2022 Q2 | 785 891 € | 78 727 € | 20 359 € | 3 |
| 2022 Q1 | 644 151 € | 71 848 € | 19 960 € | 3 |
